EnergyTechnologySmall Cap InsightsBiotechnology & HealthcareAnalytica Alpha Mining & Metals
Analytica Alpha Analytica Alpha
📊 Markets Edge Higher, Energy Leads

📊 Markets Edge Higher, Energy Leads

Bright movers in biotech and defense, but governance noise clouds outlook

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 Policy Noise Masks Big Moves

📊 Policy Noise Masks Big Moves

Biotech dilution, AI milestones, and robotics trades are reshaping the tape

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 Commodities Up, Policy Risks Ahead

📊 Commodities Up, Policy Risks Ahead

Offerpad volume jumps 136% as speculative flows hit housing and fintech

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 Risk-On Revival Faces Tests

📊 Risk-On Revival Faces Tests

AREC rallies 23% on rare-earth supply deal

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 Jackson Hole Jitters Rise

📊 Jackson Hole Jitters Rise

Rate-sensitive small caps wobble, awaiting clarity from the Fed’s next move

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 At A Crossroads

📊 At A Crossroads

Caution on rate cuts collides with double-digit gains in CGTX and AXTI

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 Rally Running Thin

📊 Rally Running Thin

Kandi’s first CATL order sparks a 13% surge

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 All Eyes on Powell

📊 All Eyes on Powell

No press release, no catalyst— ImmunoPrecise blasts higher

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 Small-Cap Trends at Risk

📊 Small-Cap Trends at Risk

IO Biotech’s 69% leap highlights both promise and fragility in small caps

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 Biotech Holds Modest Gains

📊 Biotech Holds Modest Gains

Positive Phase 2 feedback ignites sharp move in neuro-focused biotech

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 Rotation Fuels Sector Strength

📊 Rotation Fuels Sector Strength

Investor buzz builds after biotech scores key clinical milestone

Matthias Schneider
Small Cap InsightsSmall Cap Insights
+1+1
📊 Trade Policy Turmoil

📊 Trade Policy Turmoil

Markets bet on a looming Fed rate

Matthias Schneider